About Us »
Our Mission, Vision, & History
Conflict of Interest Policy
Board of Directors
News & Press
About Ann Arbor
Annual Report 2016
Our Expertise »
Clinical & Study Administration
Policy Support and Development
Communicating Research Results
Our Program Areas »
Dialysis Outcomes and Practice Patterns Study
Peritoneal Dialysis Outcomes and Practice Patterns
CKD Outcomes and Practice Patterns Study
DPM: DOPPS Practice Monitor
Health Policy and Practice Program
MIDS Contracting Vehicle
RMADA Contracting Vehicle
ESRD Quality Incentive Program
USRDS: United States Renal Data System
Health Care Disparities in ESRD
Population Health Measures: Assessment and Design
Alignment of Quality and Public Reporting Programs
Scientific and Data Coordinating Centers Program
A2ALL: Adult Living Donor Liver Transplantation
RELIVE: Renal and Lung Living Donors Evaluation
CureGN: Cure Glomerular Disease Research Network
LURN: Lower Urinary Tract Dysfunction Network
ChiLDReN: Childhood Liver Disease Research Network
TOGBI: Generic vs Branded Immunosuppression
Nephrotic Syndrome Study Network (NEPTUNE)
Patient-Centered Research Program
EPOCH-RRT: Dialysis Patient Decisions
NephCure Kidney Network PPRN
Data Management Services
ArborLink Customized Software
Customized Reporting on Chronic Kidney Disease
National Living Donor Assistance Center (NLDAC)
Our Published Research
The John Newmann Fund
A collaborative home for researchers
Every project begins with a commitment to excellence and teamwork. Sound data collection and analysis provide the foundation.
View our expertise...
A trusted source for health policy data
The best decisions are informed by knowledge. We conduct and disseminate research that is nuanced, credible, and relevant.
View our publications…
A force for improved patient care
Giving patients a chance at better health is our core mission. Expertise supported by experience is our path to success.
View our projects...
Keep in Touch
Sign up for our e-newsletter.
you can trust
Browse Past Newsletters
Read the 2016 Arbor Research Annual Report
Follow Us On
Research and News
New results from the Childhood Liver Disease Research and Education Network
Biliary Atresia is a rare disease of the liver and bile ducts that occurs in infants. A liver biopsy is a key step in distinguishing biliary atresia from other cholestatic disorders. However, the interpretation of liver biopsies in infantile cholestasis is challenging.
Presentations at the American Society of Nephrology (ASN) Kidney Week
Arbor Research is proud to present 23 abstracts at the American Society of Nephrology's Kidney Week in Chicago, IL, November 15-20, 2016.
Learn more about our presentations...
Preoperative interventions may mitigate postoperative pain in living liver donors
Little is known about how well postoperative pain is managed in living liver donors, despite the fact that pain severity is the strongest predictor of long-term disability due to chronic pain. Using data from the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL), researchers identified donor characteristics that influenced postoperative pain and evaluated postoperative pain management.
Trends in Anemia, MBD, and Interdialytic Weight Gain in US Hemodialysis Patients
The Dialysis Outcomes and Practice Patterns Study (DOPPS) Practice Monitor (DPM) has been updated with data current through June 2016, based on a national sample of US dialysis facilities.
Read a summary of the latest trends here
New investigation emphasizes negative impact of acute rejection after liver transplantation
Even though acute rejection after solid organ transplantation is often treatable, it may place recipients at increased risk of progressive graft failure and death. Liver transplantation has been considered the exception to this rule, but in a recent paper investigators repudiate older data by demonstrating increased risks of graft failure and death in liver transplant recipients who experience acute rejection.
Comparing risk factors for recurrent PSC in living and deceased donor recipients
People with Primary Sclerosing Cholangitis (PSC) experience severe liver damage, for which the only known cure is a liver transplant. After a liver transplant, PSC returns in 15 to 25 percent of patients. In a new study published in
, investigators from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL) identified several risk factors for PSC recurrence.
“I value working in a company that cares about my productivity, encourages creative solutions and work styles, and is focused on the end-goal of our mission.”
-Arbor Research employee
© 2016 by Arbor Research Collaborative for Health.